» Authors » Chuang Qi

Chuang Qi

Explore the profile of Chuang Qi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 507
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Qi C, Zhao X
J Transl Med . 2025 Jan; 23(1):33. PMID: 39789625
No abstract available.
2.
Qi C, Sun X, Huang Y, Pan Z, Lu J, Wang G, et al.
Huan Jing Ke Xue . 2024 Dec; 46(1):66-75. PMID: 39721615
The food system is an important source of greenhouse gas emissions, and the carbon footprint analysis of food consumption under the dual carbon background is of great significance for the...
3.
Wan Y, Jiang Y, Zheng W, Li X, Sun Y, Yang Z, et al.
Spectrochim Acta A Mol Biomol Spectrosc . 2024 Dec; 329():125608. PMID: 39700547
Culture media are widely used for biological research and production. It is essential for the growth of microorganisms, cells, or tissues. It includes complex components like carbohydrates, proteins, vitamins, and...
4.
Lao S, Chen Z, Wang W, Zheng Y, Xiong S, He P, et al.
NPJ Precis Oncol . 2024 Jul; 8(1):164. PMID: 39080406
Tumor-draining lymph nodes (TDLNs) are usually the first station of tumor metastasis in lung cancer. TDLNs+ have distinct pathomorphologic and tumor microenvironment (TME)-compositional patterns, which still need to be thoroughly...
5.
6.
Qi C, Zhang L, Wang W
Head Neck . 2024 Apr; 46(7):1671-1682. PMID: 38665011
Background: Circular RNAs (circRNAs) are an intriguing family of RNA molecules due to their crucial roles in the pathogenesis of oral squamous cell carcinoma (OSCC). Here, we sought to define...
7.
Wei J, Guo X, Yang X, Liu J, Duan Q, Tan Y, et al.
Future Oncol . 2023 Nov; 19(36):2395-2403. PMID: 37990937
At present, preoperative chemotherapy is the standard of care for the neoadjuvant treatment of potentially resectable gastric cancer (GC). However, because the efficacy and prognosis are not ideal, curative effects...
8.
Hong W, Hu Q, Tan Y, Duan Q, Zhang Q, Chen D, et al.
Invest New Drugs . 2023 Oct; 41(6):861-869. PMID: 37864727
Globally, gastrointestinal cancer is the most widespread neoplastic disease and the primary contributor to cancer-associated fatalities. Gastrointestinal signet ring cell carcinoma (SRCC) exhibits unique distinguishing features in several aspects when...
9.
Hu S, Liu Y, Yang Q, Chen L, Chai H, Xiao M, et al.
Invest New Drugs . 2023 Apr; 41(3):532-538. PMID: 37099161
Hepatocellular carcinoma ranks fourth in cancer-related causes of death worldwide and second in China. Patients with hepatocellular carcinoma (HCC) at the early stage have a better prognosis compared to HCC...
10.
Zhou T, Yi H, Zhu C, Yu Y, He Q, Xiao M, et al.
Invest New Drugs . 2023 Apr; 41(2):251-253. PMID: 37036581
No abstract available.